These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 11895215

  • 1. Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency.
    Link K, Bülow B, Westman K, Salmonsson EC, Eskilsson J, Erfurth EM.
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):741-8. PubMed ID: 11895215
    [Abstract] [Full Text] [Related]

  • 2. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [Abstract] [Full Text] [Related]

  • 3. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI, Bragato R, Scacchi M, Branzi G, Osculati G, Viarengo R, Leonetti G, Cavagnini F.
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [Abstract] [Full Text] [Related]

  • 4. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B, Erfurth EM.
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [Abstract] [Full Text] [Related]

  • 5. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Sowinski J, Wysocki H.
    Int J Cardiol; 2005 May 25; 101(2):257-63. PubMed ID: 15882673
    [Abstract] [Full Text] [Related]

  • 6. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr 25; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.
    Clin Endocrinol (Oxf); 2000 Sep 25; 53(3):329-36. PubMed ID: 10971450
    [Abstract] [Full Text] [Related]

  • 8. A low starting dose of genotropin in growth hormone-deficient adults.
    Janssen YJ, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1997 Jan 25; 82(1):129-35. PubMed ID: 8989246
    [Abstract] [Full Text] [Related]

  • 9. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan 25; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 10. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.
    Clin Endocrinol (Oxf); 1999 Nov 25; 51(5):565-73. PubMed ID: 10594517
    [Abstract] [Full Text] [Related]

  • 11. Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency.
    Murray RD, Howell SJ, Lissett CA, Shalet SM.
    Clin Endocrinol (Oxf); 2000 May 25; 52(5):537-42. PubMed ID: 10792331
    [Abstract] [Full Text] [Related]

  • 12. The cardiovascular risk of GH-deficient adolescents.
    Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G.
    J Clin Endocrinol Metab; 2002 Aug 25; 87(8):3650-5. PubMed ID: 12161490
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
    Jørgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS.
    Clin Endocrinol (Oxf); 1996 Dec 25; 45(6):681-8. PubMed ID: 9039333
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of growth hormone treatment in GH-deficient adults.
    Jørgensen JO, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS.
    Lancet; 1989 Jun 03; 1(8649):1221-5. PubMed ID: 2566779
    [Abstract] [Full Text] [Related]

  • 15. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A, De Rijdt D, Stevenaert A, Beckers A.
    Clin Endocrinol (Oxf); 1997 Oct 03; 47(4):485-94. PubMed ID: 9404448
    [Abstract] [Full Text] [Related]

  • 16. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar 03; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE, Attie KM, Baptista J, Genentech Collaborative Study Group.
    J Clin Endocrinol Metab; 2003 Nov 03; 88(11):5273-80. PubMed ID: 14602761
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 03; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 19. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hübner C, Savage MO, Monson JP.
    J Clin Endocrinol Metab; 2004 Aug 03; 89(8):3890-5. PubMed ID: 15292323
    [Abstract] [Full Text] [Related]

  • 20. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov 03; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.